EMMA L MCCORMACK D.O.
NPI 1598764268
Allergy & Immunology in Bloomington, IN

Active since July 15, 2005PECOS Enrolled
75/100
CMS Quality Rating
485 S LANDMARK AVE, BLOOMINGTON, IN 47403(812) 334-1198(812) 334-1199 Get Directions Write a Review

NPPES record last updated: October 23, 2012. Verified against the NPPES registry weekly; last sync: July 19, 2026.

About Emma L Mccormack D.o. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

EMMA L MCCORMACK D.O. (NPI 1598764268) is an individual allergy & immunology provider in Bloomington, Indiana, licensed in Indiana (02001726A) and active in the NPI registry since July 2005. She is enrolled in Medicare PECOS.

NPPES Registry Identity

NPI1598764268
Entity TypeIndividualFemale
Primary Taxonomy207K00000X
Provider Legal NameEMMA L MCCORMACKCredential: D.O.
Location Address485 S LANDMARK AVEBloomington, IN 47403-5005
Mailing Address485 S Landmark AveBloomington, IN 47403-5005 · (812) 334-1198 · Fax (812) 334-1199
Fax(812) 334-1199
Sole ProprietorNo
Enumeration DateJuly 15, 2005
Last NPPES UpdateOctober 23, 2012
NPI 1598764268 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyAllergy & ImmunologyAllopathic & Osteopathic Physicians
Taxonomy Code207K00000X
License Licensed in IN · 02001726A
Definition

An allergist-immunologist is trained in evaluation, physical and laboratory diagnosis, and management of disorders involving the immune system. Selected examples of such conditions include asthma, anaphylaxis, rhinitis, eczema, and adverse reactions to drugs, foods, and insect stings as well as immune deficiency diseases (both acquired and congenital), defects in host defense, and problems related to autoimmune disease, organ transplantation, or malignancies of the immune system.

485 S LANDMARK AVE, Bloomington, IN 47403

Other Identifiers 3

Medicare UPING23325IN
Medicare ID-Type Unspecified548000BIN
Medicaid200078220IN

Accepted Insurance

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare (PECOS)

Emma L Mccormack D.o. is registered in the CMS Provider Enrollment, Chain and Ownership System (PECOS).

Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 14

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Test for allergy using allergenic extract 95004
An allergy test with allergenic extract is a diagnostic method to identify substances causing allergic reactions. Small amounts of common allergens are introduced to your body, usually through skin pricks or blood tests. Your body's response helps determine your allergies.
2,995 services44 patients
Professional service for preparation and provision of 1 or more antigens 95165
This service involves the creation and supply of antigens, substances that stimulate your immune system to fight diseases. These antigens can be used in vaccines or allergy tests to help your body build defenses against specific health threats.
2,630 services107 patients
Professional service for multiple injections of allergen 95117
The professional service for multiple injections of allergens involves administering small doses of specific allergens into your body. This is done to help your immune system become less sensitive to them, reducing your allergic reaction over time. It's a safe, effective way to manage allergies.
1,278 services159 patients
Test for allergy using allergenic extract injected into skin 95024
An allergy skin test involves injecting a small amount of allergenic extract into your skin. This test helps determine if you're allergic to specific substances. If allergic, a small red bump appears at the test site. It's safe and quick.
872 services34 patients
Established patient office or other outpatient visit, 20-29 minutes 99213
This is a routine visit for patients who have already been seen by the healthcare provider. During this approximately 20-29 minute appointment, your health status will be evaluated and any necessary treatments or tests will be discussed. It's a chance to address any health concerns you may have.
127 services115 patients
Test to measure the level of nitric oxide gas 95012
A test to measure the level of nitric oxide gas helps assess inflammation in the lungs, often linked with asthma. You'll breathe into a device, and it'll provide a reading of nitric oxide levels. This helps monitor and manage respiratory conditions.
104 services88 patients

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

75/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Scored as part of a group practice

Referred Medical Equipment & Supplies CMS DME claims 6

Durable medical equipment, devices and supplies this provider ordered from DME suppliers for patients, from Medicare fee-for-service claims.

Filter, disposable, used with positive airway pressure device A7038
DME-Other DME · category DE001N
2 suppliers11 claims66 services$2.36 avg. paid by Medicare
Nebulizer, with compressor E0570
DME-Other DME · category DE000N
1 supplier24 claims24 services$5.06 avg. paid by Medicare
Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms J7605
DME-Drugs Administered Through DME · category DG006N
3 suppliers27 claims1,560 services$4.47 avg. paid by Medicare
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg J7613
DME-Drugs Administered Through DME · category DG006N
4 suppliers13 claims2,835 services$0.04 avg. paid by Medicare
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg J7626
DME-Drugs Administered Through DME · category DG000N
7 suppliers54 claims2,820 services$0.78 avg. paid by Medicare
Pharmacy dispensing fee for inhalation drug(s); per 30 days Q0513
DME-Other DME · category DE000N
7 suppliers68 claims68 services$24.50 avg. paid by Medicare
Dollar amounts are the average Medicare paid the supplier per service. They are not the cost to the patient.

Other Providers at the Same Location NPPES 2

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Allergy & Immunology
485 S LANDMARK AVE
BLOOMINGTON, IN 47403
Allergy & Immunology
485 S LANDMARK AVE
BLOOMINGTON, IN 47403

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Emma Mccormack's NPI number?

The NPI number for Emma Mccormack is 1598764268. It was assigned to this individual provider in the NPPES registry on July 15, 2005.

Where is Emma Mccormack located?

Emma Mccormack practices at 485 S Landmark Ave, Bloomington, IN 47403. The listed phone number is (812) 334-1198.

What is Emma Mccormack's specialty?

The primary specialty registered for this NPI is Allergy & Immunology with taxonomy code 207K00000X.

Is Emma Mccormack enrolled in Medicare?

Yes. Emma Mccormack is registered in the Medicare PECOS enrollment system.

What insurance does Emma Mccormack accept?

Health plans from CareSource list Emma Mccormack as in-network in at least one marketplace plan. Coverage varies by plan and year; verify with the insurer or the provider before a visit.

When was this NPI record last updated?

The NPPES record for Emma Mccormack was last updated on October 23, 2012. NPI Profile syncs with the weekly NPPES data releases published by CMS.